• Consensus Rating: Moderate Buy
  • Consensus Price Target: $46.00
  • Forecasted Upside: 22.31%
  • Number of Analysts: 6
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$37.61
▼ -0.76 (-1.98%)

This chart shows the closing price for LAZ by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Lazard Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LAZ and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LAZ

Analyst Price Target is $46.00
▲ +22.31% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Lazard in the last 3 months. The average price target is $46.00, with a high forecast of $58.00 and a low forecast of $31.00. The average price target represents a 22.31% upside from the last price of $37.61.

This chart shows the closing price for LAZ for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 6 contributing investment analysts is to moderate buy stock in Lazard. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 1 sell ratings
10/23/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 1 sell ratings
1/21/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 1 sell ratings
4/21/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 1 sell ratings
7/20/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 1 sell ratings
10/18/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 1 sell ratings
1/16/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 1 sell ratings
3/16/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 1 sell ratings
4/15/2024

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/11/2024Morgan StanleyReiterated RatingOverweight ➝ Overweight$58.00Low
3/26/2024UBS GroupBoost TargetNeutral ➝ Neutral$43.00 ➝ $44.00Low
2/5/2024UBS GroupBoost TargetNeutral ➝ Neutral$40.00 ➝ $43.00Low
1/29/2024Keefe, Bruyette & WoodsReiterated RatingOutperform$51.00Low
1/9/2024UBS GroupBoost TargetNeutral ➝ Neutral$31.00 ➝ $40.00Low
1/3/2024Wolfe ResearchUpgradePeer Perform ➝ Outperform$42.00Low
12/19/2023The Goldman Sachs GroupBoost TargetSell ➝ Sell$28.00 ➝ $31.00Low
10/27/2023Morgan StanleyBoost TargetOverweight ➝ Overweight$41.00 ➝ $45.00Low
10/12/2023Morgan StanleyLower TargetOverweight ➝ Overweight$42.00 ➝ $41.00Low
10/10/2023JMP SecuritiesLower TargetMarket Outperform ➝ Market Outperform$53.00 ➝ $50.00Low
10/3/2023UBS GroupLower TargetNeutral ➝ Neutral$37.00 ➝ $32.00Low
9/26/2023Morgan StanleyLower TargetOverweight ➝ Overweight$44.00 ➝ $42.00Low
9/19/2023The Goldman Sachs GroupDowngradeNeutral ➝ Sell$37.00 ➝ $32.00Low
7/31/2023UBS GroupBoost TargetNeutral ➝ Neutral$32.00 ➝ $37.00Low
7/13/2023Keefe, Bruyette & WoodsUpgradeUnderperform ➝ Market Perform$31.00 ➝ $36.00Low
7/12/2023Morgan StanleyUpgradeEqual Weight ➝ Overweight$36.00 ➝ $43.00Low
7/3/2023Wolfe ResearchUpgradeUnderperform ➝ Peer PerformLow
4/12/2023Morgan StanleyUpgradeUnderweight ➝ Equal Weight$29.00 ➝ $36.00Low
1/10/2023JMP SecuritiesLower TargetMarket Outperform$56.00 ➝ $53.00Low
10/31/2022Morgan StanleyBoost TargetUnderweight$28.00 ➝ $29.00Low
8/4/2022The Goldman Sachs GroupBoost TargetNeutral$32.00 ➝ $36.00Low
7/18/2022Morgan StanleyDowngradeEqual Weight ➝ Underweight$40.00 ➝ $30.00Low
7/13/2022Keefe, Bruyette & WoodsDowngradeMarket Perform ➝ Underperform$38.00 ➝ $30.00N/A
7/8/2022Piper SandlerLower TargetOverweight$45.00 ➝ $44.00N/A
4/7/2022JMP SecuritiesLower TargetMarket Outperform$58.00 ➝ $56.00Low
4/7/2022Piper SandlerLower TargetOverweight$49.00 ➝ $45.00Low
4/7/2022Wolfe ResearchDowngradePeer Perform ➝ Underperform$39.00Low
3/9/2022Piper SandlerLower TargetOverweight$62.00 ➝ $52.00Medium
3/8/2022Morgan StanleyDowngradeOverweight ➝ Equal Weight$40.00Medium
2/4/2022Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$52.00 ➝ $49.00High
1/4/2022UBS GroupLower TargetNeutral$47.00 ➝ $43.00High
12/8/2021Morgan StanleyLower TargetOverweight ➝ Overweight$61.00 ➝ $55.00High
9/30/2021Keefe, Bruyette & WoodsUpgradeMarket Perform ➝ Outperform$53.00 ➝ $58.00High
5/3/2021Credit Suisse GroupLower TargetNeutral$50.00 ➝ $49.00Medium
4/12/2021Credit Suisse GroupBoost TargetNeutral$49.00 ➝ $50.00Medium
4/7/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight$61.00High
2/9/2021ArgusBoost TargetBuy$40.00 ➝ $48.00Low
1/14/2021Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$50.00High
12/14/2020Morgan StanleyUpgradeUnderweight ➝ Equal Weight$39.00 ➝ $52.00Low
10/12/2020Morgan StanleyBoost TargetUnderweight$29.00 ➝ $39.00Medium
10/9/2020JMP SecuritiesBoost TargetMarket Outperform$40.00 ➝ $42.00Low
10/2/2020Wolfe ResearchUpgradeUnderperform ➝ Market Perform$36.00Medium
8/3/2020Morgan StanleyBoost TargetUnderweight$28.00 ➝ $29.00High
8/3/2020Credit Suisse GroupBoost TargetNeutral$32.00 ➝ $34.00High
6/22/2020Credit Suisse GroupInitiated CoverageNeutral$32.00Low
5/6/2020ArgusLower TargetBuy$51.00 ➝ $35.00Medium
5/4/2020UBS GroupBoost TargetNeutral$23.00 ➝ $24.00Low
5/1/2020CfraBoost TargetSell$22.00 ➝ $24.00Medium
4/24/2020CfraDowngradeHold ➝ Sell$46.00 ➝ $22.00High
4/9/2020JMP SecuritiesLower TargetMarket Outperform$50.00 ➝ $40.00High
4/9/2020Morgan StanleyLower TargetUnderweight$39.00 ➝ $28.00High
3/25/2020UBS GroupLower TargetNeutral$41.00 ➝ $23.00Low
3/25/2020Wolfe ResearchDowngradeMarket Perform ➝ UnderperformLow
1/31/2020CfraBoost TargetHold$43.00 ➝ $46.00Low
1/27/2020Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market PerformLow
1/26/2020Keefe, Bruyette & WoodsUpgradeMarket Perform ➝ Outperform$40.00 ➝ $48.00Medium
1/13/2020Buckingham ResearchBoost TargetNeutral$40.00 ➝ $46.00Medium
1/6/2020Wolfe ResearchUpgradeUnderperform ➝ Peer PerformN/A
11/27/2019Morgan StanleyInitiated CoverageUnderweight$35.00Low
11/20/2019Morgan StanleyInitiated CoverageUnderweight$35.00Low
10/9/2019Buckingham ResearchLower TargetNeutral$41.00 ➝ $40.00Low
7/11/2019Buckingham ResearchLower TargetNeutral$45.00 ➝ $41.00Low
6/10/2019UBS GroupDowngradeBuy ➝ Neutral$43.00 ➝ $36.00Low
(Data available from 4/16/2019 forward)

News Sentiment Rating

0.17 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 14 very positive mentions
  • 41 positive mentions
  • 8 negative mentions
  • 6 very negative mentions
9/18/2023
  • 5 very positive mentions
  • 29 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
10/18/2023
  • 5 very positive mentions
  • 37 positive mentions
  • 13 negative mentions
  • 4 very negative mentions
11/17/2023
  • 11 very positive mentions
  • 37 positive mentions
  • 5 negative mentions
  • 3 very negative mentions
12/17/2023
  • 14 very positive mentions
  • 29 positive mentions
  • 8 negative mentions
  • 1 very negative mentions
1/16/2024
  • 26 very positive mentions
  • 25 positive mentions
  • 3 negative mentions
  • 3 very negative mentions
2/15/2024
  • 30 very positive mentions
  • 46 positive mentions
  • 4 negative mentions
  • 2 very negative mentions
3/16/2024
  • 8 very positive mentions
  • 28 positive mentions
  • 5 negative mentions
  • 6 very negative mentions
4/15/2024

Current Sentiment

  • 8 very positive mentions
  • 28 positive mentions
  • 5 negative mentions
  • 6 very negative mentions

Recent Stories by Sentiment

Lazard logo
Lazard, Inc., together with its subsidiaries, operates as a financial advisory and asset management firm in North and South America, Europe, the Middle East, Asia, and Australia. It operates in two segments, Financial Advisory and Asset Management. The Financial Advisory segment offers financial advisory services, such as mergers and acquisitions, capital markets, shareholder, sovereign, geopolitical advisory, and other strategic advisory services, as well as restructuring and liability management, and capital raising and placement services. This segment offers its services to corporate, partnership, institutional, government, sovereign, and individual clients to various industry areas, including consumers, financial institutions, healthcare and life sciences, industrials, power and energy/infrastructure, real estate, technology, telecommunication, and media and entertainment. The Asset Management segment offers a range of investment solutions; investment and wealth management services in equity and fixed income strategies; asset allocation strategies; and alternative investments and private equity funds to corporations, public funds, sovereign entities, endowments and foundations, labor funds, financial intermediaries, and private clients. Lazard, Inc. was incorporated in 1848 and is headquartered in New York, New York.
Read More

Today's Range

Now: $37.61
Low: $37.23
High: $39.09

50 Day Range

MA: $39.32
Low: $37.15
High: $41.87

52 Week Range

Now: $37.61
Low: $25.82
High: $42.24

Volume

1,696,020 shs

Average Volume

1,218,389 shs

Market Capitalization

$4.24 billion

P/E Ratio

N/A

Dividend Yield

5.21%

Beta

1.46

Frequently Asked Questions

What sell-side analysts currently cover shares of Lazard?

The following sell-side analysts have issued reports on Lazard in the last twelve months: JMP Securities, Keefe, Bruyette & Woods, Morgan Stanley, StockNews.com, The Goldman Sachs Group, Inc., TheStreet, UBS Group AG, and Wolfe Research.
View the latest analyst ratings for LAZ.

What is the current price target for Lazard?

6 Wall Street analysts have set twelve-month price targets for Lazard in the last year. Their average twelve-month price target is $46.00, suggesting a possible upside of 22.3%. Morgan Stanley has the highest price target set, predicting LAZ will reach $58.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $31.00 for Lazard in the next year.
View the latest price targets for LAZ.

What is the current consensus analyst rating for Lazard?

Lazard currently has 1 sell rating, 1 hold rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for LAZ.

What other companies compete with Lazard?

How do I contact Lazard's investor relations team?

Lazard's physical mailing address is CLARENDON HOUSE 2 CHURCH STREET, HAMILTON D0, HM II. The asset manager's listed phone number is (212) 632-6000 and its investor relations email address is [email protected]. The official website for Lazard is www.lazard.com. Learn More about contacing Lazard investor relations.